PubMed Health⌕ Search

Biomedical subjects

K Blau

Publications and source records attributed to K Blau.

At least 37 records · Page 2Linked to original sources
PubMed1977

Mass spectrometric and nuclear magnetic resonance confirmation of a 3,3-spirocyclic indole derivative formed from melatonin and related acyl tryptamines.

When melatonin is reacted with pentafluoropropionic anhydride for selected ion monitoring or electron capture gas chromatographic analysis a volatile product results. Examination of the product by combined gas chromatography mass spectrometry has established that the molecular weight of 360 corresponds to the addition of one molecule of pentafluoropropionic acid followed by dehydration. Further spectroscopic and chemical examination using mass spectrometry and nuclear magnetic resonance with isotopic labelling has established that the product is a 3,3-spirocyclic indole derivative. Several analogous compounds were also examined and their mass spectra studied.

Indoles↗
PubMed1975

Monoamine metabolites and related compounds in human amniotic fluid: assay by gas chromatography and gas chromatography-mass spectrometry.

Some catecholamine metabolites and related compounds have been identified in amniotic fluid obtained by transabdominal amniocentesis at various stages of pregnancy, including 4-hydroxy-3-methoxymandelic acid, 4-hydroxy-3-methoxyphenylglycol, 4-hydroxy-3-methoxyphenylcetic acid, p-hydroxypheny lacetic acid, p-hydroxphenyllactic acid and N-benzoylglycine (hippuric acid). Analysis was by gas chromatography with electron capture detection and by gas chromatography-mass spectrometry. Two of these compounds were determined quantitatively, free 4-hydroxy-3-methoxphenylglycol and p-hydroxyphenllactic acid: the concentration of the former increased with advancing pregnancy and that of the latter tended to decrease. Conjugated 4-hydoxy-3-methoxyphenylglycol could not be determined with accuracy as appreciable amounts of the unconjugated compound were found in the snail extract used for enzymatic hydrolysis. Assay of 4-hydroxy-3-methoxyphenylglycol in amniotic fluid is likely to be of diagnostic importance in the prenatal diagnosis of congenital neuroblastoma. Although 4-hydroxy-3-methoxyphenylethanol, 3, 4-dihydroxymandelic acid and 3, 4-dihydroxyphenylacetic acid were specifically looked for in amniotic fluid, they could not be detected.

Amniocentesis↗
PubMed1973

Phenethylamines in brain and liver of rats with experimentally induced phenylketonuria-like characteristics.

1. Phenethylamines were extracted from brain and liver of rats with phenylketonuria-like characteristics produced in vivo by inhibition of phenylalanine hydroxylase (EC 1.14.3.1) with p-chlorophenylalanine, with or without phenylalanine administration. To protect amines against oxidation by monoamine oxidase, pargyline was also administered. 2. beta-Phenethylamine was the major compound found in brain and liver. beta-Phenethanolamine and octopamine were also present, in lesser amounts, and the concentrations of these three amines paralleled blood phenylalanine concentrations. By comparison, tissues from control animals had only very low concentrations of these amines. 3. Small amounts of normetadrenaline, m-tyramine and 3-methoxytyramine were also found. 4. The inhibitors used, p-chlorophenylalanine and pargyline, gave rise to p-chlorophenethylamine and benzylamine respectively, the first via decarboxylation, the second probably by breakdown during extraction. 5. Distribution of phenethylamines in different brain regions and in subcellular fractions of rat brain cells was also investigated. The content of phenethylamine was highest in the striatum. 6. These findings are discussed in the light of changes occurring in human patients with uncontrolled phenylketonuria.

Animals↗
PubMed1972

Aromatic acids derived from phenylalanine in the tissues of rats with experimentally induced phenylketonuria-like characteristics.

1. Aromatic acids were extracted from brain and liver of rats with phenylketonuria-like characteristics produced by administration of phenylalanine, either alone or in combination with p-chlorophenylalanine. The metabolism of the aromatic acids in these tissues was measured by gas chromatography. 2. At 1h after an intraperitoneal injection of l-phenylalanine (1g/kg) in 23-day-old rats, the phenyl-lactate concentration was 2.2mug/g in the liver and 0.43mug/g in the brain, and the concentration of o-hydroxyphenylacetate was 0.26mug/g in the liver. 3. Phenylacetate concentrations in brain and liver were 0.26 and 0.14mug/g respectively. 4. Suckling rats produced phenyl-lactate less rapidly than weanling rats, but accumulated higher concentrations in longer-term experiments. 5. Intraperitoneal injections of phenyl-lactic acid showed that this compound could directly penetrate the blood-brain barrier, and could produce similar brain/liver ratios of phenyllactate to those found after phenylalanine injection. 6. Qualitative and quantitative similarities in urinary excretion of aromatic acids between the rats used in this study and human patients with uncontrolled phenylketonuria indicate that a patient with a circulating phenylalanine concentration of the order of those achieved in the experimental animal may have aromatic acid concentrations in brain and liver comparable with those found in the rats used in the present study.

Animals↗